| ISIN | LU2492015610 |
|---|---|
| Valorennummer | 120608809 |
| Bloomberg Global ID | |
| Fondsname | Kieger Sustainable Healthcare Fund Class A CHF (H) Accumulating |
| Fondsanbieter |
Kieger AG
Kieger AG Limmatstrasse 264, CH-8005 Zürich Telefon: +41 44 444 18 44 Web: https://kieger.com/ E-Mail: info@kieger.com |
| Fondsanbieter | Kieger AG |
| Vertreter in der Schweiz |
ACOLIN Fund Services AG Zürich Telefon: +41 44 396 96 96 |
| Distributor(en) | |
| Anlagekategorie | Aktienfonds |
| EFC-Kategorie | |
| Anteilskategorie | Accumulation |
| Domizilland | Luxemburg |
| Konditionen bei der Ausgabe | keine Ausgabekommission und/oder Gebühren zugunsten des Fonds (Ausgabe erfolgt zum Inventarwert) |
| Konditionen bei der Rücknahme | Keine Rücknahmekommission und/oder Gebühren zugunsten des Fonds (Rücknahme erfolgt zum Inventarwert) |
| Investment-Strategie *** | The investment objective of the Sub-Fund is to achieve long term capital growth by principally investing in equities of healthcare and healthcare related issuers worldwide (including Emerging Markets). The Sub-Fund aims to have a positive impact on society by investing in sustainable companies with current or future activities positively contributing to good health and well-being. The objective is reached by investing in innovative companies with differentiated products and/or services that are leaders in sustainability as identified through a proprietary sustainability framework developed by the Investment Manager. |
| Besonderheiten |
| Aktueller Preis * | 99.74 CHF | 11.12.2025 |
|---|---|---|
| Vorheriger Preis * | 98.69 CHF | 10.12.2025 |
| 52 Wochen Hoch * | 104.77 CHF | 05.02.2025 |
| 52 Wochen Tief * | 89.41 CHF | 07.08.2025 |
| NAV * | 99.74 CHF | 11.12.2025 |
| Ausgabepreis * | ||
| Rücknahmepreis * | ||
| Schlusskurs * | ||
| Indikativer Minimalpreis | ||
| Fondsvermögen *** | 187'637'280 | |
| Anteilsklassevermögen *** | 1'104'746 | |
| Trading Information SIX | ||
| YTD-Performance | +2.95% |
31.12.2024 - 11.12.2025
31.12.2024 11.12.2025 |
|---|---|---|
| 1 Monat | +0.45% |
11.11.2025 - 11.12.2025
11.11.2025 11.12.2025 |
| 3 Monate | +4.13% |
11.09.2025 - 11.12.2025
11.09.2025 11.12.2025 |
| 6 Monate | +2.54% |
11.06.2025 - 11.12.2025
11.06.2025 11.12.2025 |
| 1 Jahr | -2.05% |
11.12.2024 - 11.12.2025
11.12.2024 11.12.2025 |
| 2 Jahre | +2.82% |
11.12.2023 - 11.12.2025
11.12.2023 11.12.2025 |
| 3 Jahre | -1.14% |
12.12.2022 - 11.12.2025
12.12.2022 11.12.2025 |
| 5 Jahre | -0.26% |
04.08.2022 - 11.12.2025
04.08.2022 11.12.2025 |
| Kapitalbeteiligungsquote in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Anteil am Gesamtvermögen in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Immobilienquote in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ADDI | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ADDI Date | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Eli Lilly and Co | 6.36% | |
|---|---|---|
| UnitedHealth Group Inc | 5.85% | |
| Abbott Laboratories | 5.75% | |
| AstraZeneca PLC | 5.68% | |
| Novartis AG Registered Shares | 5.51% | |
| Roche Holding AG | 5.40% | |
| Boston Scientific Corp | 4.02% | |
| Vertex Pharmaceuticals Inc | 4.00% | |
| Novo Nordisk AS Class B | 3.53% | |
| Danaher Corp | 3.44% | |
| Letzte Daten-Aktualisierung | 30.09.2025 | |
| TER | |
|---|---|
| Datum TER | |
| Performance Fee *** | |
| PTR | |
| Max. Management Fee *** | 0.85% |
| Ongoing Charges *** | 1.34% |
|
SRRI ***
|
|
| Datum SRRI *** | 30.04.2024 |